Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.7030
-0.0210 (-2.90%)
Jul 24, 2026, 5:29 PM CET
Isofol Medical AB Market Cap
Isofol Medical AB has a market cap or net worth of 232.04 million as of July 24, 2026. Its market cap has increased by 36.82% in one year.
Market Cap
232.04M
Enterprise Value
121.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.70
ChartMarket Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 232.04M, a decrease of -72.81%. That is a compound annual growth rate of -13.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 225.31M | 9.94% |
| Dec 30, 2025 | 204.93M | -42.85% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intervacc AB | 381.03M |
| Sprint Bioscience AB | 377.75M |
| Xbrane Biopharma AB | 206.05M |
| IRLAB Therapeutics AB | 200.46M |
| Simris Group AB (PUBL) | 182.22M |
| Elicera Therapeutics AB | 175.52M |
| Xintela AB | 162.78M |
| Diamyd Medical AB | 162.42M |